Informações:
Falhas:
ID
23264
Descrição
AI(I)DA Acarbose and the Subclinical Inflammation; ODM derived from: https://clinicaltrials.gov/show/NCT00558883
Link
https://clinicaltrials.gov/show/NCT00558883
Palavras-chave
Versões (1)
- 01/07/2017 01/07/2017 -
Transferido a
1 de julho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes Mellitus NCT00558883
Eligibility Type 2 Diabetes Mellitus NCT00558883
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00558883
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
in this study patients with type 2 diabetes are included, who fulfil the following criteria:
boolean
C0011860 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus WHO classification | Age
Item
type 2 diabetes by who criteria, aged 30-75
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C4267671 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Glycosylated hemoglobin A | Oral Glucose Tolerance Test Plasma glucose
Item
hba1c ≥ 6.5 % < 8.0 % and/or 2h 75 ogtt plasma glucose ≥ 11.1 mmol/l
boolean
C0019018 (UMLS CUI [1])
C0029161 (UMLS CUI [2,1])
C0455280 (UMLS CUI [2,2])
C0029161 (UMLS CUI [2,1])
C0455280 (UMLS CUI [2,2])
White Blood Cell Count procedure Fasting | Diabetes Mellitus, Non-Insulin-Dependent | C-reactive protein; high sensitivity (hsCRP)
Item
fasting leucocytes count ≥ 6.2 gpt/l (median for newly diagnosed type 2 patients in riad) and/or hscrp ≥ 1.0 mg/dl and < 10 mg/dl (earlier 2.8 mg/dl)
boolean
C0023508 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2])
C0973334 (UMLS CUI [3])
C0015663 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2])
C0973334 (UMLS CUI [3])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Criteria None
Item
excluded were patients with one of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C0549184 (UMLS CUI [1,2])
C0549184 (UMLS CUI [1,2])
Medical contraindication Acarbose
Item
contraindication for acarbose
boolean
C1301624 (UMLS CUI [1,1])
C0050393 (UMLS CUI [1,2])
C0050393 (UMLS CUI [1,2])
Gastrointestinal Disease chronic
Item
chronic gastrointestinal disease
boolean
C0017178 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,2])
Therapeutic procedure Diabetes Mellitus
Item
prior antidiabetic treatment
boolean
C0087111 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
C0011849 (UMLS CUI [1,2])
Statins | Anti-Inflammatory Agents
Item
intake of statins or drugs with antiinflammatory effects
boolean
C0360714 (UMLS CUI [1])
C0003209 (UMLS CUI [2])
C0003209 (UMLS CUI [2])
Inflammatory disorder | Chronic inflammatory disorder
Item
acute or chronic inflammatory diseases
boolean
C1290884 (UMLS CUI [1])
C1290886 (UMLS CUI [2])
C1290886 (UMLS CUI [2])
Myocardial Infarction | Cerebrovascular accident
Item
mi or stroke < 6 months before entry
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
Immune System Diseases
Item
immune diseases
boolean
C0021053 (UMLS CUI [1])
Neoplastic disease
Item
neoplasia
boolean
C1882062 (UMLS CUI [1])
Weight loss Disease
Item
diseases with acute weight loss
boolean
C1262477 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])